The collaboration aims to expand the footprint of Intelsius and its core strategy of offering products globally with local supply.
Intelsius CEO David Walsh said the company’s partnership with BioCore as the exclusive distributor of its solutions will allow them to better ensure patient safety in the growing pharma market.
"The partnership enables Intelsius to meet the increasing demand for temperature control and regulatory compliant packaging systems for the life science sector in this region," Walsh added.
BioCore president and CEO Hyung-Sik Choie said the partnership with Intelsius will have an impact on the accuracy of trials and will also improve the safety of the patients participating.
Intelsius is a designer, manufacturer and distributor of temperature-controlled and regulatory-compliant packaging solutions.